FinTrust Capital Advisors’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-100
Closed -$6K 1249
2022
Q3
$6K Hold
100
﹤0.01% 988
2022
Q2
$7K Hold
100
﹤0.01% 976
2022
Q1
$7K Sell
100
-109
-52% -$7.63K ﹤0.01% 1015
2021
Q4
$25K Sell
209
-800
-79% -$95.7K 0.01% 679
2021
Q3
$135K Buy
1,009
+284
+39% +$38K 0.04% 343
2021
Q2
$117K Buy
+725
New +$117K 0.03% 381